Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.
Department of Radiology and Diagnostic Imaging, National Institute of the Ministry of Interior and Administration in Warsaw, Warsaw, Poland.
Med Sci Monit. 2023 Oct 26;29:e941455. doi: 10.12659/MSM.941455.
BACKGROUND Number of confirmed COVID-19 deaths per million population in Poland between November 2020 and May 2021 was one of the largest in Europe. This retrospective study was conducted at a single center in Poland between November 2020 and May 2021to evaluate the morbidity and mortality rates in 581 patients hospitalized with COVID-19. MATERIAL AND METHODS A retrospective single-center study was conducted in a dedicated COVID-19 hospital from November, 2020 to May, 2021. The data of 581 hospitalized patients were analyzed. Multimorbidity was assessed using the Charlson Comorbidity Index, including chronic kidney, respiratory, cardiovascular diseases, diabetes mellitus, cancer, and dementia. The observation period covered admission to the hospital for severe COVID-19 until discharge or death. Diagnosis of COVID-19 was confirmed by quantitative reverse transcription polymerase chain reaction test. Statistical analysis was carried out in the IBM SPSS Statistics program. RESULTS The mortality rate was 35% of all admitted patients. Lung damage was the cause of death in 60%, bacterial superinfection in 26%, arterial thrombosis or thromboembolism in 9%, and heart failure in 5% of patients. The chi-square test showed a significant relationship between sex and the cause of death related to COVID-19 pneumonia and bacterial ventilator-associated pneumonia (VAP). CONCLUSIONS The findings from this study supports findings from other countries that between November 2020 and May 2021, before SARS-CoV-2 vaccination programs were fully implemented and before effective medications and antiviral agents were developed, patients with severe COVID-19 had high rates of morbidity and mortality.
波兰 2020 年 11 月至 2021 年 5 月期间每百万人口中确诊的 COVID-19 死亡人数在欧洲位居前列。本回顾性研究在波兰的一家单一中心进行,旨在评估 2020 年 11 月至 2021 年 5 月期间因 COVID-19 住院的 581 例患者的发病率和死亡率。
2020 年 11 月至 2021 年 5 月期间,在一家专门的 COVID-19 医院进行了回顾性单中心研究。分析了 581 名住院患者的数据。采用 Charlson 合并症指数评估多系统疾病,包括慢性肾脏病、呼吸系统疾病、心血管疾病、糖尿病、癌症和痴呆。观察期包括因严重 COVID-19 入院至出院或死亡。COVID-19 的诊断通过定量逆转录聚合酶链反应检测确认。统计分析在 IBM SPSS Statistics 程序中进行。
所有入院患者的死亡率为 35%。肺部损伤是 60%死亡患者的死亡原因,细菌合并感染占 26%,动脉血栓形成或血栓栓塞占 9%,心力衰竭占 5%。卡方检验显示,性别与 COVID-19 肺炎和细菌性呼吸机相关性肺炎(VAP)相关的死亡原因之间存在显著关系。
本研究结果支持其他国家的研究结果,即 2020 年 11 月至 2021 年 5 月期间,在 SARS-CoV-2 疫苗接种计划全面实施之前,在开发有效的药物和抗病毒药物之前,严重 COVID-19 患者的发病率和死亡率较高。